Table 1.
Sample N and Weighted Percent Receiving Recommended Clinical Preventive Services
|
||||||||
---|---|---|---|---|---|---|---|---|
All Women
|
Women With Disability
|
Other Women
|
Separate Multiple Logistic Regressions on Clinical Preventive Services
|
|||||
N | % | N | % | N | % | AOR for Disability | 95% CI | |
Mammogram within last 2 years (n = 2,913)* | 2,452 | 81.0 | 612 | 76.6 | 1,840 | 82.4 | 0.69† | 0.51–0.95 |
Pap test within last 3 years (n = 3,025)* | 2,575 | 84.4 | 628 | 77.0 | 1,947 | 86.7 | 0.64‡ | 0.48–0.85 |
Ever had colorectal screening (n = 3,132)* | 1,041 | 33.2 | 340 | 40.8 | 701 | 30.9 | 1.54‡ | 1.16–2.04 |
Influenza immunization within the last year (n = 3,137)* | 1,268 | 41.6 | 392 | 50.1 | 876 | 39.0 | 1.37‡ | 1.08–1.73 |
Cholesterol screening within last 5 years (n = 3,073) | 2,796 | 91.3 | 742 | 92.6 | 2,054 | 90.9 | 0.74 | 0.48–1.13 |
Note. Based on women sampled in 1999–2002 panels 4, 5, and 6 of Medical Expenditure Panel Survey who were aged 51–64 in the baseline year, followed-up for 2 consecutive years, and alive by the end of the follow-up. Figures in parentheses represent total sample size. The sample sizes vary due to missing data. The multiple logistic regressions on each type of preventive services controlled for enrollee’s sociodemographic characteristics and medical conditions and included intercept term. Reference group for the disability status are individuals without any disability. All statistical except the sample sizes were adjusted for the complex survey design of MEPS.
Abbreviations: AOR, adjusted odds ratio; CI, confidence intervals.
Significant group difference (p < .05) in receipt of clinical preventive services by disability status.
Significant effect at 1% in the multiple logistic regressions.
Significant effect at 5% level in the multiple logistic regressions.